Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorouracil implant for malignant ascites from digestive tract tumors
ChiCTR1900024357Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluorouracil in malignant ascites, sponsored by Renmin Hospital of Wuhan University. Primary endpoint: Response rate. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
fluorouracil
03
Conditions
malignant ascites
Beyond the preview
Go deeper on ChiCTR1900024357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024357.